Clinical Trial Update: Efficacy and Safety of the Use of Memantine for Preserving Cognition in Adult Patients With Epilepsy [NA]

View source ↗

Summary

A clinical trial evaluating memantine for preserving cognition in adults with epilepsy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Namenda (memantine)

Snippet

Sponsor: University of California, Davis | Conditions: Epilepsy | NA | Status: WITHDRAWN